Stéphane Desgranges

Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice

Jianfeng Guo, Julien Ogier, Stéphane Desgranges et al. · Biomaterials · 2012 · 128 citations · Full text

Pharmacy, Oncology, Pharmaceutics +14

A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery

Aoife O’Mahony, Julien Ogier, Stéphane Desgranges et al. · Organic & Biomolecular Chemistry · 2012 · 70 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Perfluorocarbon nanodroplets stabilized by fluorinated surfactants: characterization and potentiality as theranostic agents

Ksenia Astafyeva, Lucie Somaglino, Stéphane Desgranges et al. · Journal of Materials Chemistry B · 2015 · 54 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

In Vitro Investigations of the Efficacy of Cyclodextrin-siRNA Complexes Modified with Lipid-PEG-Octaarginine: Towards a Formulation Strategy for Non-viral Neuronal siRNA Delivery

Aoife O’Mahony, Stéphane Desgranges, Julien Ogier et al. · Pharmaceutical Research · 2012 · 41 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

β-Lactam-host defence peptide conjugates as antibiotic prodrug candidates targeting resistant bacteria

Stéphane Desgranges, Carol C. Ruddle, Liam P. Burke et al. · RSC Advances · 2012 · 35 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17